These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37272890)

  • 1. Sortilin acts as an endocytic receptor for α-synuclein fibril.
    Ishiyama S; Hasegawa T; Sugeno N; Kobayashi J; Yoshida S; Miki Y; Wakabayashi K; Fukuda M; Kawata Y; Nakamura T; Sato K; Ezura M; Kikuchi A; Takeda A; Aoki M
    FASEB J; 2023 Jul; 37(7):e23017. PubMed ID: 37272890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
    Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
    Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
    Gerez JA; Prymaczok NC; Rockenstein E; Herrmann US; Schwarz P; Adame A; Enchev RI; Courtheoux T; Boersema PJ; Riek R; Peter M; Aguzzi A; Masliah E; Picotti P
    Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcellular propagation of fibrillar α-synuclein from enteroendocrine to neuronal cells requires cell-to-cell contact and is Rab35-dependent.
    Rodrigues PV; de Godoy JVP; Bosque BP; Amorim Neto DP; Tostes K; Palameta S; Garcia-Rosa S; Tonoli CCC; de Carvalho HF; de Castro Fonseca M
    Sci Rep; 2022 Mar; 12(1):4168. PubMed ID: 35264710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction.
    Gentzel RC; Toolan D; Jinn S; Schachter JB; Ma L; Kahle PJ; Smith SM; Marcus JN
    Neurobiol Aging; 2021 Oct; 106():12-25. PubMed ID: 34225000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
    Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
    Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
    Codolo G; Plotegher N; Pozzobon T; Brucale M; Tessari I; Bubacco L; de Bernard M
    PLoS One; 2013; 8(1):e55375. PubMed ID: 23383169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
    Kahle PJ
    Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.
    Alzghool OM; van Dongen G; van de Giessen E; Schoonmade L; Beaino W
    Mov Disord; 2022 May; 37(5):936-948. PubMed ID: 35289424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice.
    Matsuo K; Kawahata I; Melki R; Bousset L; Owada Y; Fukunaga K
    Brain Res; 2021 Jun; 1760():147383. PubMed ID: 33636166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.
    Lloyd GM; Sorrentino ZA; Quintin S; Gorion KM; Bell BM; Paterno G; Long B; Prokop S; Giasson BI
    Acta Neuropathol; 2022 Jun; 143(6):663-685. PubMed ID: 35488930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.
    Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J
    Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathology of α-synuclein in Parkinson's disease.
    Choong CJ; Mochizuki H
    Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
    Boutros SW; Raber J; Unni VK
    J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties.
    Fassler M; Benaim C; George J
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies].
    Cheng A; Fukunaga K
    Nihon Yakurigaku Zasshi; 2022; 157(6):396-400. PubMed ID: 36328545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo imaging of alpha-synuclein with antibody-based PET.
    Roshanbin S; Xiong M; Hultqvist G; Söderberg L; Zachrisson O; Meier S; Ekmark-Lewén S; Bergström J; Ingelsson M; Sehlin D; Syvänen S
    Neuropharmacology; 2022 May; 208():108985. PubMed ID: 35149134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.